Cancer.net Podcasts

Research into new forms of biologic therapy, such as immunotherapy or targeted therapy, have made dramatic advances in treating and managing cancer, but these therapies can be very expensive. You may be familiar with generic drugs, which are identical copies of brand-name drugs, and are often much cheaper. However, the manufacturing process for biologic therapies is so complex, it is not possible for a different manufacturer to make an identical copy. In this podcast, Dr. Gary Lyman discusses biosimilar agents, which are similar, but not identical, copies of these drugs.  Treatments, Tests, and Procedures